A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study)

« Previous Next »European Journal of Surgical Oncology
Volume 36, Issue 6 , Pages 546-551, June 2010

T. Yoshikawa
- Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama 241-0815, Japan
- Corresponding author. Tel.: +81 45 391 5761; fax: +81 45 361 4692.
K. Omura
- Department of Surgery, Kanazawa University, 13-1 Takara-machi, Kanazawa, Japan
O. Kobayashi
- Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama 241-0815, Japan
A. Nashimoto
- Department of Surgery, Niigata Cancer Center, 2-15-3 Kawagishi-cho, Chuo-Ku, Niigata 951-8566, Japan
A. Takabayashi
- Department of Surgery, Kitano Hospital, 2-4-20 Ogicho, Kita-Ku, Osaka 530-8480, Japan
T. Yamada
- Department of Surgery, Ishikawa Prefectural Central Hospital, 2-1 Kuratsukihigashi, Kanazawa 920-8530, Japan
H. Yamaue
- Department of Surgery, Wakayama University, 811-1 Kimiidera, Wakayama 641-8510, Japan
M. Fujii
- Department of Surgery, Nihon University, 1-8-13 Kandasurugadai, Chiyoda-Ku, Tokyo 101-8309, Japan
T. Yamaguchi
- Department of Gastrointestinal Tract Surgery, Cancer Institute Hospital, 3-10-6 Ariake, Koto-Ku, Tokyo 135-8550, Japan
T. Nakajima
- Japan Clinical Cancer Research Organization, 3-10-6 Ariake, Koto-Ku, Tokyo 135-8550, Japan